|
|
Article: Dutch antibody specialist PanGenetics (Utrecht) has licensed an undisclosed antibody from US pharma company Schering-Plough (Kenoilworth, New Jersey).(Projects & Technology)(Brief article)
- Article from:
- Chemistry and Industry
- Article date:
- December 18, 2006
CopyrightCOPYRIGHT 2006 Society of Chemical Industry. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Dutch antibody specialist PanGenetics (Utrecht) has licensed an undisclosed antibody from US pharma company Schering-Plough (Kenoilworth, New Jersey). After PanGenetics initial clinical safety and efficacy evaluations, Schering-Plough has the option to assume full responsibiltiy for the further development, or enter into a cooperative development arrangement. The deal has a ...
Related newspaper, magazine, and journal articles:
|
|
Article: CEO of New Jersey Drug Maker Schering-Plough ...
Knight Ridder/Tribune Business News;
November 14, 2002 ;
635 words
... ... and I know that Schering-Plough is well-prepared to face ... Kogan's watch, Schering-Plough, which employs about 7,000 people in New Jersey, had several years of explosive ... Claritin. But Schering-Plough also was cited for manufacturing ...
|
|